microdosing a glp-1 is popular, but there's little evidence it works Is Microdosing GLP-1s All Hype?

In human studies, treatment with GLP-1 receptor agonists has been associated with reductions in circulating inflammatory markers

Krishnan, A

While it usually resolves on its own, you should be evaluated by a physician

Meanwhile, Nestle, which owns Vital Proteins, launched a completely separate brand called Vital Pursuit targeting people already on GLP-1 medications

The genetic context upstream of every GLP-1 prescription A GLP-1 offering does not examine the genetics that shape how your body meets these compounds

Wentz is well versed in finding and evaluating emerging research to help address her clients' unique challenges